Annual EBITDA
-$408.41M$473.98M-722.84%
Summary
- Current Value
- As of today, OSCR annual EBITDA is -$408.41M, down -722.84% on
- Historical Performance
- OSCR annual EBITDA is up +31.34% over the past 3 years, down -3.53% over the past 5 years
- All-Time High Comparison
- OSCR annual EBITDA is currently -722.84% below its historical high of $65.57M set on
- 3-Year Low Comparison
- OSCR annual EBITDA is +31.34% above its 3-year low of -$594.79M reached on an earlier date
- Sector Comparison
- OSCR annual EBITDA is higher than 2.22% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$408.41M | -722.8% | +31.3% | -3.5% | -61.8% | |
| Quarterly EBITDA | $6.54M | +105.0% | +111.8% | +103.1% | +107.0% | |
| TTM EBITDA | $756.58M | +463.6% | +338.5% | +237.8% | +910.0% | |
| Price | $31.05 | +122.6% | +356.6% | +154.9% | – | |
| PE Ratio | 13.03 | – | – | – | – | |
| Annual Revenue | $11.70B | +27.5% | +195.2% | +2428.4% | +2296.9% | |
| Annual EPS | -$1.69 | -1864.8% | +40.8% | +0.7% | -54.8% | |
| -$437.30M | -1408.3% | +28.3% | -7.8% | -68.6% | ||
| Annual Net Income | -$442.90M | -1795.6% | +27.3% | -8.9% | -69.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $65.57M | -722.8% | |
| 5Y | $65.57M | -722.8% | |
| All | $65.57M | -722.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$594.79M | N/A | +31.3% |
| 5Y | -$594.79M | +31.3% | |
| All | -$594.79M | +31.3% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$408.41M | -722.8% | |
| $65.57M | +127.7% | |
| -$236.61M | +60.2% | |
| -$594.79M | -7.0% |
| Year | Value | Change |
|---|---|---|
| -$555.98M | -40.9% | |
| -$394.50M | -56.2% | |
| -$252.49M | - |
FAQ
- What is the current annual EBITDA of OSCR?
- As of today, OSCR annual EBITDA is -$408.41M
- What is 1-year change in OSCR annual EBITDA?
- OSCR annual EBITDA is down -722.84% year-over-year
- What is 3-year change in OSCR annual EBITDA?
- OSCR annual EBITDA is up +31.34% over the past 3 years
- How far is OSCR annual EBITDA from its all-time high?
- OSCR annual EBITDA is currently -722.84% below its historical high of $65.57M set on December 31, 2024
- How does OSCR annual EBITDA rank versus sector peers?
- OSCR annual EBITDA is higher than 2.22% of companies in Healthcare sector
- When is OSCR next annual earnings release?
- The next annual earnings release for OSCR is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$6.54M$382.50M-98.32%
Summary
- Current Value
- As of today, OSCR quarterly EBITDA is $6.54M, down -98.32% on
- Historical Performance
- OSCR quarterly EBITDA is up +104.96% year-over-year, up +111.77% over the past 3 years
- All-Time High Comparison
- OSCR quarterly EBITDA is currently -99.07% below its historical high of $705.79M set on
- 3-Year Low Comparison
- OSCR quarterly EBITDA is +101.90% above its 3-year low of -$344.80M reached on
- Sector Comparison
- OSCR quarterly EBITDA is higher than 74.03% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $6.54M | -98.3% | +105.0% | +111.8% | +103.1% | |
| Annual EBITDA | -$408.41M | – | -722.8% | +31.3% | -3.5% | |
| TTM EBITDA | $756.58M | +22.4% | +463.6% | +338.5% | +237.8% | |
| Price | $31.05 | +0.9% | +122.6% | +356.6% | +154.9% | |
| PE Ratio | 13.03 | -42.0% | – | – | – | |
| Quarterly Revenue | $5.14B | +5.3% | +72.1% | +256.9% | +1057.5% | |
| Quarterly EPS | $0.48 | -55.5% | +191.1% | +264.7% | +147.5% | |
| $0.00 | -100.0% | +100.0% | +100.0% | +100.0% | ||
| Quarterly Net Income | $167.30M | -53.8% | +221.7% | +354.6% | +179.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $705.79M | -99.1% | |
| 3Y | $705.79M | -99.1% | |
| 5Y | $705.79M | -99.1% | |
| All | $705.79M | -99.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$344.80M | +101.9% | |
| 3Y | -$344.80M | +101.9% | |
| 5Y | -$344.80M | +101.9% | |
| All | -$344.80M | +101.9% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of OSCR?
- As of today, OSCR quarterly EBITDA is $6.54M
- What is OSCR quarterly EBITDA most recent change?
- OSCR quarterly EBITDA was down -98.32% on September 30, 2026
- What is 1-year change in OSCR quarterly EBITDA?
- OSCR quarterly EBITDA is up +104.96% year-over-year
- How far is OSCR quarterly EBITDA from its all-time high?
- OSCR quarterly EBITDA is currently -99.07% below its historical high of $705.79M set on March 31, 2026
- How does OSCR quarterly EBITDA rank versus sector peers?
- OSCR quarterly EBITDA is higher than 74.03% of companies in Healthcare sector
- When is OSCR next earnings release?
- The next earnings release for OSCR is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$756.58M$138.52M+22.41%
Summary
- Current Value
- As of today, OSCR TTM EBITDA is $756.58M, up +22.41% on
- Historical Performance
- OSCR TTM EBITDA is up +463.63% year-over-year, up +338.48% over the past 3 years
- All-Time High Comparison
- OSCR TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- OSCR TTM EBITDA is +285.25% above its 3-year low of -$408.41M reached on
- Sector Comparison
- OSCR TTM EBITDA is higher than 90.81% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $756.58M | +22.4% | +463.6% | +338.5% | +237.8% | |
| Annual EBITDA | -$408.41M | – | -722.8% | +31.3% | -3.5% | |
| Quarterly EBITDA | $6.54M | -98.3% | +105.0% | +111.8% | +103.1% | |
| Price | $31.05 | +0.9% | +122.6% | +356.6% | +154.9% | |
| PE Ratio | 13.03 | -42.0% | – | – | – | |
| TTM Revenue | $17.47B | +14.1% | +54.8% | +222.0% | +1064.5% | |
| TTM EPS | $2.38 | +74.0% | +311.8% | +249.1% | +191.9% | |
| $729.10M | +23.6% | +405.9% | +312.0% | +229.5% | ||
| TTM Net Income | $855.72M | +55.3% | +451.1% | +346.4% | +251.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $756.58M | at high | |
| 3Y | $756.58M | at high | |
| 5Y | $756.58M | at high | |
| All | $756.58M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$408.41M | +285.3% | |
| 3Y | -$408.41M | +285.3% | |
| 5Y | -$594.79M | +227.2% | |
| All | -$594.79M | +227.2% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of OSCR?
- As of today, OSCR TTM EBITDA is $756.58M
- What is OSCR TTM EBITDA most recent change?
- OSCR TTM EBITDA was up +22.41% on September 30, 2026
- What is 1-year change in OSCR TTM EBITDA?
- OSCR TTM EBITDA is up +463.63% year-over-year
- How far is OSCR TTM EBITDA from its all-time high?
- OSCR TTM EBITDA is currently at its all-time high
- How does OSCR TTM EBITDA rank versus sector peers?
- OSCR TTM EBITDA is higher than 90.81% of companies in Healthcare sector
- When is OSCR next earnings release?
- The next earnings release for OSCR is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- OSCR Official Website www.hioscar.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1568651/000156865126000011/0001568651-26-000011-index.htm
- OSCR Profile on Yahoo Finance finance.yahoo.com/quote/OSCR
- OSCR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/oscr
